Dr. Kuang-Yuh Chyu, MD

Dr. Chyu practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Chyu's NPI, 1437110764, was assigned on March 28, 2006. Dr. Chyu holds California license A52203.

Dr. Chyu's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Chyu's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chyu practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chyu's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Chyu is licensed in California.

CMS data shows 177 Medicare services from Dr. Chyu across 2 procedure codes in 2024, for 73 Medicare patients. Medicare paid $26,738 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 73 Medicare patients who saw Dr. Chyu in 2024. The largest group is 65 to 74, with 25 patients. 75% of them have chronic kidney disease, and 75% have heart failure. 51% are also on Medicaid. Their average risk score is 4.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chyu's median patient age at 61, with 32% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Chyu for performance year 2024, reported as part of a group. Dr. Chyu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 35 papers to Dr. Chyu, published from 2005 to 2025. 2013 was the busiest year, with 3. The most frequent topics are Atherosclerosis, Disease Models, Animal and Vaccines. Dr. Chyu has published most often in PLoS One. Dr. Chyu's most frequent co-authors are Prediman K. Shah, MD, Bojan Cercek, MD and Daniel S. Berman, MD.

Dmand AI links Dr. Chyu to 1 clinical trial. Conditions studied include Homozygous Familial Hypercholesterolemia and Hyperlipoproteinemia Type II. Open Payments lists research payments to Dr. Chyu that name 1 trial.

CMS Open Payments shows 1 general payment to Dr. Chyu from 1 drug or device company in 2017. Food and beverage make up the largest share, 100% of the total. INSYS Therapeutics Inc paid the most, $16. It also lists 3 research payments totaling $1,424 in 2017, naming 1 clinical trial.